| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160878 For therapy of central nervous system disorders related to or affected by the 5-HT6 receptor |
| 07/20/2006 | US20060160876 Indole derivatives |
| 07/20/2006 | US20060160874 anticarcinogenic agent; antitumor; antiproliferative; 1-ethyl 5-methyl 3-[(3,5-difluorobenzoyl)amino]-1H-thieno[3,2-c]pyrazole-1,5-dicarboxylate; N-benzyl-3-{[4-(4-ethylpiperazin-1-yl)benzoyl]amino}-1H-thieno[3,2-c]pyrazole-5-carboxamide; can treat neurodegenerative disorders, angiogenesis and metastasis |
| 07/20/2006 | US20060160840 Tetrahydroisoquinolines as factor Xa inhibitors |
| 07/20/2006 | US20060160830 3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 07/20/2006 | US20060160829 Thienopyrimidine compounds and use thereof |
| 07/20/2006 | US20060160827 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | CA2593268A1 Macrocyclic compounds useful as bace inhibitors |
| 07/19/2006 | EP1680427A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 07/19/2006 | EP1680406A1 N-substituted benzene sulfonamides |
| 07/19/2006 | CN1805686A Mitotic kinesin inhibitors |
| 07/19/2006 | CN1803806A Preparation of ekb-569 and related intermediates |
| 07/19/2006 | CN1803802A Method for synthesizing oxazole pyridone compound |
| 07/19/2006 | CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists |
| 07/19/2006 | CN1264847C 1-oxa-3,9-diaza-spiro [5,5] undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/18/2006 | US7078521 By reaction of pyrrolobenzothiazepin-9-one with amine to give the corresponding enamine, which is subsequently transformed into the final compound |
| 07/18/2006 | US7078495 minimal cross reactivity with tacolimus metaolites; antibody is conjugated with a detectable label; sample reacted with an enzyme labelled tacrolimus analogue, total signal present is measured; test kits |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/18/2006 | US7078409 Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
| 07/18/2006 | US7078399 Antiulcer agents; antiinflammatory agents; therapy for ear infections |
| 07/13/2006 | WO2006021457A3 Pyrimidine derivatives |
| 07/13/2006 | WO2006017468A3 Antibacterial agents |
| 07/13/2006 | WO2006013095A3 Condensed pyridines as kinase inhibitors |
| 07/13/2006 | WO2005123087A3 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 07/13/2006 | US20060154958 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/13/2006 | US20060154957 Crystalline clopidogrel hydrobromide and processes for preparation thereof |
| 07/13/2006 | US20060154945 e.g. (R)-3'-(5-phenyl-thiophen-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5'-oxazolidin]-2'-one; nicotinic acetylcholine receptor agonist; antidepressant, neurodegenerative diseses; Alzheimer's disease, cognitive or attention disorders, smoking cessation, schizophrenia, analgesia |
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/13/2006 | US20060154875 Thienoisoquinoline-phenylsulfonamides and their use as ER-NFkappaB inhibitors |
| 07/13/2006 | CA2592900A1 Nitrogen containing bicyclic compounds and therapeutical use thereof |
| 07/13/2006 | CA2584425A1 1, 5, 6-substituted-2-oxo-3-cyano-1, 6a-diaza-tetrahydro-fluoranthenes |
| 07/12/2006 | EP1678185A1 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole compounds for the treatment of tuberculosis |
| 07/12/2006 | EP1389212B1 3,7-diazabicyclo 3.3.1| formulations as anti-arrythmic compounds |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 07/12/2006 | CN1263751C Novel compounds |
| 07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
| 07/11/2006 | US7074804 CCI-779 Isomer C |
| 07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
| 07/11/2006 | CA2206532C Novel amidinonaphthyl derivative or salt thereof |
| 07/06/2006 | WO2006070275A1 Process for obtaining levofloxacin free from salts |
| 07/06/2006 | US20060148843 e.g.1-(4-Chloro-benzyl)-3-(2-methyl-thieno[2,3-c]pyridin-3-yl)-urea; 2-Methyl-thieno[2,3-c]pyridin-3-yl)-carbamic acid 4-trifluoromethylsulfanyl-benzyl ester; controlling pain, urinary incontinence, bladder overactivity, and inflammatory thermal hyperalgesia in mammals |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/05/2006 | EP1676848A1 Polymorphous forms of rifaximin as antibiotics |
| 07/05/2006 | EP1676847A1 Polymorphous forms of rifaximin as antibiotics |
| 07/05/2006 | EP1675859A1 Modulators of serotonin receptors |
| 07/05/2006 | EP1675852A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/05/2006 | EP1675585A2 Large conductance calcium-activated k channel opener |
| 07/05/2006 | EP1139755B9 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 07/05/2006 | CN1796390A 9a,11 ¿C dinitrogen ¿C acene [b] fluorenone,preparation method and application in preparing medication |
| 07/05/2006 | CN1796389A Antibacterial compound A-13, and application in preparing antibacterial drug |
| 07/05/2006 | CN1262551C Substituted oxazolidinones and their use in the field of blood coagulation |
| 06/29/2006 | WO2006069386A1 Method of purifying tacrolimus |
| 06/29/2006 | WO2006069333A1 Method of purifying macrolides |
| 06/29/2006 | WO2006069258A1 Substituted heterocyclic compounds and methods of use |
| 06/29/2006 | WO2006068932A2 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
| 06/29/2006 | US20060142506 Heterobifunctional poly(ethylene glycol) and uses thereof |
| 06/29/2006 | US20060142355 Carboxylic acid peri-substituted bicyclics for occlusive artery disease |
| 06/29/2006 | US20060142325 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 06/29/2006 | US20060142318 eating disorders of disturbed fundus such as dyspepsia, early satiety, bloating, anorexia; fundic relaxation; 1-[1-[(2,3-dihydro[1,4]dioxino[2,3-b]pyridin-3-yl)methyl]-4-piperidinyl]-2-imidazolidinone; improved pharmacokinetics, less vasoconstriction, side effect reduction, sustain release |
| 06/29/2006 | US20060142317 3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof |
| 06/29/2006 | US20060142278 Mitotic kinesin inhibitors |
| 06/29/2006 | US20060142267 [6-hydroxy-2-(2-hydroxy-benzyl)-benzo [b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(2-hydroxy-benzyl)-naphthalen-1-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; 6-(2-hydroxy-benzyl)-5-{hydroxy-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methyl}-naphthalen-2-ol |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | US20060142262 4-[1-(4-Methanesulfonyl-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy]-piperidine-1-carboxylic acid tert-butyl ester, for example, as antidiabetic and antiobesity agents |
| 06/29/2006 | CA2592119A1 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 06/29/2006 | CA2591946A1 Substituted heterocyclic compounds and methods of use |
| 06/29/2006 | CA2590254A1 Rapamycin derivatives and the uses thereof in the treatment of neurological disorders |
| 06/29/2006 | CA2590155A1 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
| 06/29/2006 | CA2586700A1 Method of purifying tacrolimus |
| 06/29/2006 | CA2586692A1 Method of purifying macrolides |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/28/2006 | EP1272653B1 Methods for ansamitocin production |
| 06/28/2006 | EP0924213B1 Pyridobenzoxazine derivatives |
| 06/28/2006 | CN1794996A Macrocyclic quinazoline derivatives as antiproliferative agents |
| 06/28/2006 | CN1793146A Process for the production of 9-pyro-3, 7-biazobicyclononane(3.3.1) |
| 06/28/2006 | CN1261163C Stabilization of macrolides |
| 06/27/2006 | USRE39151 Process for the preparation and purification of thiol-containing maytansinoids |
| 06/27/2006 | US7067526 28-epirapalogs |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067519 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067507 Macrocycles useful in the treatment of Alzheimer's disease |
| 06/27/2006 | US7067286 Cystobacterineae host cells containing heterologous PKS genes for the synthesis of polykedtides |
| 06/22/2006 | WO2006065654A1 Bridged ring nk1 antagonists |
| 06/22/2006 | WO2006065480A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | WO2006065209A1 Nicotinic acetylcholine receptor ligands |
| 06/22/2006 | WO2006044869A8 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 06/22/2006 | WO2006040111A3 Heteroatoms-containing tricyclic compounds |
| 06/22/2006 | WO2005121327A3 Biosynthetic gene cluster for the production of a complex polyketide |
| 06/22/2006 | US20060135781 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof |
| 06/22/2006 | US20060135571 Imidazo(2,1-b)-1,3,4-thiadiazole sulfoxides and sulfones |
| 06/22/2006 | US20060135552 1-(2-Methyl-4-phenyl-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-b]pyridin-3-yl)-ethanone for example; central nervous system disorders including anxiety, depression, epilepsy, schizophrenia, cerebral palsy, post-traumatic stress disorder, spinal cord injury, multiple sclerosis |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135539 Thienopyridazinones and their use in modulation of autoimmune disease |
| 06/22/2006 | US20060135529 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |